Article Text

Download PDFPDF
OP 022
  1. Pieter De Cock1,
  2. Joseph Standing2,
  3. Charlotte Barker3,
  4. Annick de Jaeger4,
  5. Mieke Carlier5,
  6. Evelyn Dhont6,
  7. Alain Verstraete6,
  8. Joris Delanghe6,
  9. Hugo Robays1,
  10. Peter De Paepe7
  1. 1Ghent University Hospital, Hospital Pharmacy, Ghent, Belgium
  2. 2University College London, Institute of child Health, Infectious diseases and Microbiology unit, London, UK
  3. 3University of London, St George's, University of London, London, UK
  4. 4Ghent University Hospital, Pediatric Intensive Care Department
  5. 5Ghent University Hospital, Department of Clinical Chemistry, Microbiology and Immunology, Ghent, Belgium
  6. 6Ghent University Hospital, Department of Clinical Chemistry, Microbiology and Immunology, Ghent, Belgium
  7. 7Ghent University, Heymans Institute of Pharmacology


Background Amoxicillin/clavulanate is commonly used to treat community-acquired infections on the pediatric intensive care unit. Few data are available to guide dosing in this vulnerable population.

Methods This prospective pharmacokinetic study enrolled patients admitted to the pediatric intensive care unit in whom intravenous amoxicillin-clavulanate was indicated (25–35 mg/kg q6h). Serial blood samples were obtained following the first and steady-state doses and amoxicillin/clavulanate concentrations were measured by a validated high-pressure liquid chromatography (HPLC)-tandem mass spectrometry method. Population pharmacokinetic analysis and Monte Carlo simulations were conducted using NONMEM’ 7.3.

Results Three hundred twenty-five amoxicillin and 151 clavulanate blood samples were collected from 50 patients with a median age of 2.58 years (range: 0.08–15 years). A 3-compartment model for amoxicillin and a two-compartment model for clavulanate best described the data, in which allometric weight scaling and maturation functions were added a priori to scale for size and age. In addition, serum Cystatin C (sCysC) ‘as a marker for renal function’ and concomitant treatment with vasopressors were identified to have a significant influence on amoxicillin clearance. The typical population values of clearance for amoxicillin and clavulanate were 17.97 L/H/70 kg (95% CI:15.33–21.30 L/H/70 kg) and 12.20 L/H/70 kg (95% CI:10.54–14.55 L/H/70 kg), respectively. Four hourly dosing of 25 mg/kg (based on the amoxicillin component) was required to achieve 40% of the dosing interval for amoxicillin concentrations to be above MIC, and for clavulanate levels to be maintained above 2 mg/L. For patients with augmented renal function a 1 hour infusion was preferable to bolus dosing to achieve the therapeutic target.

Conclusions Current dosing regimens result in subtherapeutic concentrations in the early period of sepsis due to augmented renal clearance, which risks treatment failure in critically ill children.

  • ESDP

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.